Bayer Bets on Appeals, More Trials, Following $2B Roundup Verdict
Law.com | Amanda Bronstad
Despite losing three verdicts in California over Roundup, including this week’s $2 billion jury award, Bayer AG isn’t backing down.
In fact, its lawyers say, the fight has just begun.
“Jury trials are complicated things, and unpredictable things,” said Bayer attorney William Hoffman, a partner at Arnold & Porter Kaye Scholer in Washington, D.C. “We think we have very strong arguments based on the science and on the regulatory determination. Some aspects of that defense were hamstrung by evidentiary decisions, and some aspects of our defense were weakened by the determination of the court to let some shaky evidence in. Those are the kinds of things that will be the focus of our appeal, and those errors are part of the explanation for what’s happened.”